Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Healthcare startup...

    Healthcare startup ekincare raises over Rs 25 crore in Series A funding

    Farhat NasimWritten by Farhat Nasim Published On 2019-11-14T10:10:38+05:30  |  Updated On 14 Nov 2019 10:10 AM IST
    Healthcare startup ekincare raises over Rs 25 crore in Series A funding

    New Delhi: Health benefits start-up ekincare on Wednesday said it has raised USD 3.6 million (about 25.8 crores) in a funding round from investors like Ventureast and Eight Roads.


    The round was led by a new investor (whose name the company did not disclose), with participation from existing investors including Ventureast, Eight Roads and Touchstone equities, a statement said.

    The latest round takes the total funding raised by ekincare to USD 5.6 million, it added.

    The funds will be used to strengthen ekincare's technology platform, business development, marketing and expand its portfolio of offerings in the corporate health benefits market, the statement said.

    Also Read: Onco.com, dedicated cancer care platform, raises $7 million in Series A funding


    Currently, ekincare caters to over 200 companies, managing health of more than three lakh employees on its platform. It offers preventive health services like telemedicine, e-pharmacy, health checks, vision and dental care, access to gyms, and other services.


    Citing a report by Transparency Market Research, the company said the corporate health market size in the Asia Pacific was valued at USD 4.5 billion in 2018 and, is expected to grow at a CAGR (Compound annual growth rate) of 9 per cent over the next 10 years.

    "Our patent-pending technology recognises patterns across disparate health data sets, discerning differences between consumer segments and behaviours to engage people better," ekincare founder and CEO Kiran Kalakuntla said

    Also Read: HealthAssure raises over Rs 17 crore in Series A funding led by Blume Ventures
    dental caree-pharmacyeight roadseKincareepharmacyhealth checksHealthcareSeries A fundingstartupTelemedicineTouchstone equitiesVentureastvision
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok